S&P 500   3,117.72 (+0.16%)
DOW   27,685.95 (+0.13%)
QQQ   202.72 (+0.14%)
AAPL   265.44 (+1.41%)
FB   199.21 (+0.25%)
MSFT   149.99 (+0.09%)
GOOGL   1,324.03 (+0.39%)
AMZN   1,744.38 (-0.93%)
CGC   18.61 (+1.25%)
NVDA   208.72 (-0.33%)
MU   46.56 (+0.56%)
BABA   200.15 (+3.31%)
GE   10.80 (-1.01%)
TSLA   331.23 (-0.54%)
T   38.22 (+0.32%)
AMD   39.68 (-0.05%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.68 (+1.12%)
NFLX   302.76 (-0.51%)
BAC   33.19 (+0.12%)
GILD   66.01 (-1.11%)
DIS   148.10 (-0.12%)
S&P 500   3,117.72 (+0.16%)
DOW   27,685.95 (+0.13%)
QQQ   202.72 (+0.14%)
AAPL   265.44 (+1.41%)
FB   199.21 (+0.25%)
MSFT   149.99 (+0.09%)
GOOGL   1,324.03 (+0.39%)
AMZN   1,744.38 (-0.93%)
CGC   18.61 (+1.25%)
NVDA   208.72 (-0.33%)
MU   46.56 (+0.56%)
BABA   200.15 (+3.31%)
GE   10.80 (-1.01%)
TSLA   331.23 (-0.54%)
T   38.22 (+0.32%)
AMD   39.68 (-0.05%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.68 (+1.12%)
NFLX   302.76 (-0.51%)
BAC   33.19 (+0.12%)
GILD   66.01 (-1.11%)
DIS   148.10 (-0.12%)
S&P 500   3,117.72 (+0.16%)
DOW   27,685.95 (+0.13%)
QQQ   202.72 (+0.14%)
AAPL   265.44 (+1.41%)
FB   199.21 (+0.25%)
MSFT   149.99 (+0.09%)
GOOGL   1,324.03 (+0.39%)
AMZN   1,744.38 (-0.93%)
CGC   18.61 (+1.25%)
NVDA   208.72 (-0.33%)
MU   46.56 (+0.56%)
BABA   200.15 (+3.31%)
GE   10.80 (-1.01%)
TSLA   331.23 (-0.54%)
T   38.22 (+0.32%)
AMD   39.68 (-0.05%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.68 (+1.12%)
NFLX   302.76 (-0.51%)
BAC   33.19 (+0.12%)
GILD   66.01 (-1.11%)
DIS   148.10 (-0.12%)
S&P 500   3,117.72 (+0.16%)
DOW   27,685.95 (+0.13%)
QQQ   202.72 (+0.14%)
AAPL   265.44 (+1.41%)
FB   199.21 (+0.25%)
MSFT   149.99 (+0.09%)
GOOGL   1,324.03 (+0.39%)
AMZN   1,744.38 (-0.93%)
CGC   18.61 (+1.25%)
NVDA   208.72 (-0.33%)
MU   46.56 (+0.56%)
BABA   200.15 (+3.31%)
GE   10.80 (-1.01%)
TSLA   331.23 (-0.54%)
T   38.22 (+0.32%)
AMD   39.68 (-0.05%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.68 (+1.12%)
NFLX   302.76 (-0.51%)
BAC   33.19 (+0.12%)
GILD   66.01 (-1.11%)
DIS   148.10 (-0.12%)
Log in

OTCMKTS:AMAR - Amarillo Biosciences Stock Price, Forecast & News

$0.35
+0.05 (+16.67 %)
(As of 12/5/2019 03:22 PM ET)
Today's Range
$0.31
Now: $0.35
$0.35
50-Day Range
$0.30
MA: $0.40
$0.45
52-Week Range
$0.12
Now: $0.35
$0.54
Volume6,390 shs
Average Volume4,457 shs
Market Capitalization$14.08 million
P/E RatioN/A
Dividend YieldN/A
Beta0.01
Amarillo Biosciences, Inc. engages in the development of biologics for the treatment of human and animal diseases. The company owns or licenses five issued patents related to the low-dose oral delivery of interferon; and owns one issued patent on its dietary supplement, Maxisal. It focuses on research for the treatment of human disease indications primarily influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha. Amarillo Biosciences, Inc. was founded in 1984 and is based in Amarillo, Texas.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:AMAR
CUSIPN/A
Phone806-376-1741

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$80,000.00
Book Value$0.02 per share

Profitability

Net Income$-1,340,000.00
Net Margins-10,718.75%

Miscellaneous

Employees3
Market Cap$14.08 million
Next Earnings Date4/21/2020 (Estimated)
OptionableNot Optionable

Receive AMAR News and Ratings via Email

Sign-up to receive the latest news and ratings for AMAR and its competitors with MarketBeat's FREE daily newsletter.


Amarillo Biosciences (OTCMKTS:AMAR) Frequently Asked Questions

What is Amarillo Biosciences' stock symbol?

Amarillo Biosciences trades on the OTCMKTS under the ticker symbol "AMAR."

How were Amarillo Biosciences' earnings last quarter?

Amarillo Biosciences Inc (OTCMKTS:AMAR) announced its earnings results on Wednesday, November, 14th. The company reported ($0.01) EPS for the quarter. The firm earned $0.02 million during the quarter. Amarillo Biosciences had a negative return on equity of 428.46% and a negative net margin of 10,718.75%. View Amarillo Biosciences' Earnings History.

When is Amarillo Biosciences' next earnings date?

Amarillo Biosciences is scheduled to release their next quarterly earnings announcement on Tuesday, April 21st 2020. View Earnings Estimates for Amarillo Biosciences.

Has Amarillo Biosciences been receiving favorable news coverage?

Media coverage about AMAR stock has trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Amarillo Biosciences earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Amarillo Biosciences.

Who are some of Amarillo Biosciences' key competitors?

What other stocks do shareholders of Amarillo Biosciences own?

Who are Amarillo Biosciences' key executives?

Amarillo Biosciences' management team includes the folowing people:
  • Dr. Stephen T. Chen, Chairman, CEO, Pres, CFO & COO (Age 69)
  • Mr. Bernard Cohen, VP of Admin. (Age 66)
  • Mr. Edward L. Morris, Gen. Counsel & Sec.
  • Dr. Yung-Hsiang Hung, Medical Affairs Director & Consultant
  • Dr. Ching-Yuan Lee, Director of R&D and Consultant

How do I buy shares of Amarillo Biosciences?

Shares of AMAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Amarillo Biosciences' stock price today?

One share of AMAR stock can currently be purchased for approximately $0.35.

How big of a company is Amarillo Biosciences?

Amarillo Biosciences has a market capitalization of $14.08 million and generates $80,000.00 in revenue each year. Amarillo Biosciences employs 3 workers across the globe.View Additional Information About Amarillo Biosciences.

What is Amarillo Biosciences' official website?

The official website for Amarillo Biosciences is http://www.amarbio.com/.

How can I contact Amarillo Biosciences?

Amarillo Biosciences' mailing address is 4134 BUSINESS PARK DRIVE, AMARILLO TX, 79110. The company can be reached via phone at 806-376-1741 or via email at [email protected]


MarketBeat Community Rating for Amarillo Biosciences (OTCMKTS AMAR)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  56 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  111
MarketBeat's community ratings are surveys of what our community members think about Amarillo Biosciences and other stocks. Vote "Outperform" if you believe AMAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel